Edwards Lifesciences says updated TAVR CMS coverage will expand access
Edwards Lifesciences said updated CMS TAVR coverage will expand patient access as part of a phased rollout. The company reaffirmed 2026 guidance and plans to give a 2027 outlook in December; analysts also updated ratings.